← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

ALB logoAlbemarle Corporation(ALB)Earnings, Financials & Key Ratios

ALB•NYSE
$192.61
$22.7B mkt cap·Price updated May 6, 2026
SectorBasic MaterialsIndustrySpecialty ChemicalsSub-IndustryCatalysts and process chemicals
AboutAlbemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.Show more
  • Revenue$5.14B-4.4%
  • EBITDA$754M+1773.8%
  • Net Income-$511M+56.7%
  • EPS (Diluted)-5.75+48.7%
  • Gross Margin13.06%+1065.8%
  • EBITDA Margin14.67%+1850.2%
  • Operating Margin1.82%+115.4%
  • Net Margin-9.93%+54.7%
  • ROE-5.11%+57.0%
  • ROIC0.58%+115.7%
  • Debt/Equity0.34-4.9%
  • Interest Coverage0.45+111.8%
Analysis→Technical→

ALB Key Insights

Albemarle Corporation (ALB) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓15 consecutive years of dividend growth
  • ✓Momentum leader: RS Rating 90 (top 10%)
  • ✓Strong 5Y sales CAGR of 10.4%

✗Weaknesses

  • ✗Weak 3Y average ROE of 0.2%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ALB Price & Volume

Albemarle Corporation (ALB) stock price & volume — 10-year historical chart

Loading chart...

ALB Growth Metrics

Albemarle Corporation (ALB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years6.17%
5 Years10.45%
3 Years-11.1%
TTM7.87%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM75.93%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM69.34%

Return on Capital

10 Years6.95%
5 Years5.4%
3 Years-0.64%
Last Year0.64%

ALB Recent Earnings

Albemarle Corporation (ALB) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 6/12 qtrs (50%)
Q1 2026Latest
Feb 11, 2026
EPS
$0.53
Est $0.42
-26.8%
Revenue
$1.4B
Est $1.3B
+6.0%
Q4 2025
Nov 5, 2025
EPS
$0.19
Est $0.86
+77.9%
Revenue
$1.3B
Est $1.3B
+2.4%
Q3 2025
Jul 30, 2025
EPS
$0.11
Est $0.83
+113.3%
Revenue
$1.3B
Est $1.3B
+4.6%
Q2 2025
Apr 30, 2025
EPS
$0.18
Est $0.62
+71.0%
Revenue
$1.1B
Est $1.2B
-7.5%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 11, 2026
$0.53vs $0.42-26.8%
$1.4Bvs $1.3B+6.0%
Q4 2025Nov 5, 2025
$0.19vs $0.86+77.9%
$1.3Bvs $1.3B+2.4%
Q3 2025Jul 30, 2025
$0.11vs $0.83+113.3%
$1.3Bvs $1.3B+4.6%
Q2 2025Apr 30, 2025
$0.18vs $0.62+71.0%
$1.1Bvs $1.2B-7.5%
Based on last 12 quarters of dataView full earnings history →

ALB Peer Comparison

Albemarle Corporation (ALB) competitors in Catalysts and process chemicals — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
SQM logoSQMSociedad Química y Minera de Chile S.A.Direct Competitor13.35B93.46-65.82-39.35%12.12%9.48%0.93
LAC logoLACLithium Americas Corp.Direct Competitor1.45B5.99-28.52-26.94%0.02
ECL logoECLEcolab Inc.Product Competitor74.4B263.4236.182.16%12.91%21.96%0.96
ASH logoASHAshland Inc.Product Competitor2.5B54.59-2.97-13.68%-39.03%-37.54%0.83
FMC logoFMCFMC CorporationProduct Competitor1.85B14.79-0.83-18.34%-72.93%-82.27%2.00
HWKN logoHWKNHawkins, Inc.Product Competitor3.47B167.1141.476.01%7.75%15.88%0.35
IOSP logoIOSPInnospec Inc.Product Competitor1.92B77.6716.63-3.65%6.56%8.23%0.06
TSLA logoTSLATesla, Inc.Supply Chain1.5T398.53369.01-2.93%3.96%4.75%0.10

Compare ALB vs Peers

Albemarle Corporation (ALB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SQM

Most directly comparable listed peer for ALB.

Scale Benchmark

vs TSLA

Larger-name benchmark to compare ALB against a more recognizable public peer.

Peer Set

Compare Top 5

vs SQM, LAC, ECL, ASH

ALB Income Statement

Albemarle Corporation (ALB) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue3.07B3.37B3.59B3.13B3.33B7.32B9.62B5.38B5.14B5.49B
Revenue Growth %14.75%9.86%6.35%-12.83%6.36%119.96%31.38%-44.08%-4.37%7.87%
Cost of Goods Sold1.95B2.15B2.33B2.13B2.32B4.23B8.42B5.32B4.47B4.48B
COGS % of Revenue63.43%63.82%64.93%68.18%69.7%57.85%87.51%98.88%86.94%-
Gross Profit
1.12B▲ 0%
1.22B▲ 8.7%
1.26B▲ 3.1%
995.55M▼ 20.9%
1.01B▲ 1.3%
3.09B▲ 206.0%
1.2B▼ 61.1%
60.24M▼ 95.0%
671.62M▲ 1014.9%
1.02B▲ 0%
Gross Margin %36.57%36.18%35.07%31.82%30.3%42.15%12.49%1.12%13.06%18.53%
Gross Profit Growth %15.75%8.69%3.09%-20.91%1.3%205.97%-61.08%-94.98%1014.92%-
Operating Expenses500.92M496.74M573.46M469.84M475.81M584.13M959.89M696.25M577.83M592.26M
OpEx % of Revenue16.31%14.72%15.98%15.02%14.3%7.98%9.98%12.95%11.24%-
Selling, General & Admin422.29M426.69M515.17M410.63M421.79M512.14M874.16M609.52M526.43M545.79M
SG&A % of Revenue13.75%12.64%14.35%13.12%12.67%7%9.09%11.33%10.24%-
Research & Development84.33M70.05M58.29M59.21M54.03M71.98M85.72M86.72M51.4M46.47M
R&D % of Revenue2.75%2.08%1.62%1.89%1.62%0.98%0.89%1.61%1%-
Other Operating Expenses0000000000
Operating Income
622.56M▲ 0%
724.31M▲ 16.3%
685.32M▼ 5.4%
525.71M▼ 23.3%
532.66M▲ 1.3%
2.5B▲ 369.6%
241.12M▼ 90.4%
-636.01M▼ 363.8%
93.79M▲ 114.7%
305.04M▲ 0%
Operating Margin %20.27%21.46%19.09%16.8%16.01%34.17%2.51%-11.83%1.82%5.55%
Operating Income Growth %22.16%16.34%-5.38%-23.29%1.32%369.62%-90.36%-363.77%114.75%-
EBITDA819.49M925.01M898.81M757.7M786.66M2.8B671.07M-45.07M754.37M801.97M
EBITDA Margin %26.68%27.41%25.04%24.22%23.64%38.28%6.98%-0.84%14.67%14.6%
EBITDA Growth %11.37%12.88%-2.83%-15.7%3.82%256.23%-76.05%-106.72%1773.84%403.32%
D&A (Non-Cash Add-back)196.93M200.7M213.48M231.98M254M300.84M429.94M590.94M660.58M496.92M
EBIT622.56M724.31M685.32M525.71M532.66M2.5B241.12M-636.01M93.79M71.54M
Net Interest Income-115.35M-52.41M-57.7M-73.12M-61.48M-122.97M-116.07M-165.62M-207.65M-158.67M
Interest Income0000000000
Interest Expense115.35M52.41M57.7M73.12M61.48M122.97M116.07M165.62M207.65M125.55M
Other Income/Expense-91.28M159.65M7.2M-24.67M-303.27M704.26M1.86B-412.39M-402.12M-404.5M
Pretax Income
531.28M▲ 0%
883.97M▲ 66.4%
692.52M▼ 21.7%
501.04M▼ 27.6%
229.39M▼ 54.2%
3.21B▲ 1297.5%
2.1B▼ 34.5%
-1.05B▼ 149.9%
-308.33M▲ 70.6%
-99.45M▲ 0%
Pretax Margin %17.29%26.19%19.29%16.01%6.89%43.79%21.84%-19.5%-6%-1.81%
Income Tax431.82M144.83M88.16M54.42M29.45M390.59M430.28M87.08M156.88M182.37M
Effective Tax Rate %81.28%16.38%12.73%10.86%12.84%12.18%20.48%-8.31%-50.88%-183.37%
Net Income
54.85M▲ 0%
693.56M▲ 1164.5%
533.23M▼ 23.1%
375.76M▼ 29.5%
123.67M▼ 67.1%
2.69B▲ 2075.0%
1.57B▼ 41.5%
-1.18B▼ 175.0%
-510.63M▲ 56.7%
-274.57M▲ 0%
Net Margin %1.79%20.55%14.86%12.01%3.72%36.75%16.36%-21.93%-9.93%-5%
Net Income Growth %-91.48%1164.47%-23.12%-29.53%-67.09%2074.96%-41.5%-174.96%56.71%75.93%
Net Income (Continuing)99.47M739.14M604.36M446.62M199.94M2.82B1.67B-1.14B-465.21M-237.1M
Discontinued Operations0000000000
Minority Interest143.15M173.79M161.33M200.37M180.34M208.22M252.92M238.17M248.1M257.94M
EPS (Diluted)
0.49▲ 0%
6.34▲ 1193.9%
5.02▼ 20.8%
3.52▼ 29.9%
1.06▼ 69.9%
22.84▲ 2054.7%
13.36▼ 41.5%
-11.20▼ 183.8%
-5.75▲ 48.7%
-2.32▲ 0%
EPS Growth %-91.37%1193.88%-20.82%-29.88%-69.89%2054.72%-41.51%-183.83%48.66%69.34%
EPS (Basic)0.496.405.033.531.0722.9713.41-11.20-5.75-
Diluted Shares Outstanding112.38M109.46M106.32M106.81M116.54M117.79M117.77M117.52M117.7M118.61M
Basic Shares Outstanding110.91M108.43M105.95M106.4M115.84M117.12M117.32M117.52M117.7M117.85M
Dividend Payout Ratio256.26%20.85%28.54%43.06%143.81%6.86%11.9%---

ALB Balance Sheet

Albemarle Corporation (ALB) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets2.48B2B2.23B2.21B1.99B5.19B5.22B3.84B4.01B3.26B
Cash & Short-Term Investments1.14B555.32M613.11M746.72M439.27M1.5B889.9M1.19B1.62B1.09B
Cash Only1.14B555.32M613.11M746.72M439.27M1.5B889.9M1.19B1.62B1.09B
Short-Term Investments0000000000
Accounts Receivable619.39M697.89M752.45M530.84M700.06M1.45B1.84B1.07B764.77M522.72M
Days Sales Outstanding73.5975.4876.5161.9276.7872.2369.6572.3354.2849.96
Inventory592.78M700.54M768.98M750.24M798.62M2.08B2.16B1.5B1.18B1.35B
Days Inventory Outstanding111.04118.71120.43128.36125.67178.9593.73103.1496.27116.19
Other Current Assets41.74M1.5M6.93M120.85M5.8M6.72M6.59M4.75M374.19M299.7M
Total Non-Current Assets5.27B5.58B7.64B8.24B8.98B10.27B13.05B12.77B12.37B11.88B
Property, Plant & Equipment2.49B3.02B5.04B5.35B6.06B7.09B9.63B9.45B8.73B11.82B
Fixed Asset Turnover1.23x1.12x0.71x0.58x0.55x1.03x1.00x0.57x0.59x0.56x
Goodwill1.61B1.57B1.58B1.67B1.6B1.62B1.63B1.58B1.5B1.49B
Intangible Assets421.5M386.14M354.62M349.11M308.95M287.87M261.86M230.75M214.23M207.62M
Long-Term Investments534.06M528.72M579.81M656.24M912.01M1.15B1.37B1.12B900.93M3.73B
Other Non-Current Assets188.87M63.11M63.92M198.95M78.7M75.95M137.25M332.26M1B-182.47M
Total Assets
7.75B▲ 0%
7.58B▼ 2.2%
9.86B▲ 30.1%
10.45B▲ 6.0%
10.97B▲ 5.0%
15.46B▲ 40.8%
18.27B▲ 18.2%
16.61B▼ 9.1%
16.37B▼ 1.4%
15.14B▲ 0%
Asset Turnover0.40x0.45x0.36x0.30x0.30x0.47x0.53x0.32x0.31x0.33x
Asset Growth %-5.03%-2.18%30.06%5.98%5.01%40.85%18.21%-9.09%-1.42%-20.08%
Total Current Liabilities1.2B1.18B1.41B1.8B1.87B2.74B3.56B1.97B1.8B1.58B
Accounts Payable418.54M522.52M574.14M483.22M647.99M2.05B2.09B943.89M913.53M677.15M
Days Payables Outstanding78.488.5589.9282.68101.97176.8890.5664.7974.5868.34
Short-Term Debt422.01M307.29M187.34M804.68M389.92M2.13M625.76M398.02M74.08M74.63M
Deferred Revenue (Current)00000002.12M93.09M93.09M
Other Current Liabilities95.33M77.81M58.89M102.71M100.72M145.88M168.36M157.15M331.96M1.5B
Current Ratio2.06x1.69x1.58x1.22x1.06x1.89x1.47x1.95x2.23x2.23x
Quick Ratio1.57x1.10x1.03x0.81x0.64x1.13x0.86x1.19x1.57x1.57x
Cash Conversion Cycle106.23105.64107.03107.61100.4874.372.83110.6775.9797.81
Total Non-Current Liabilities2.73B2.64B4.36B4.18B3.29B4.52B5.05B4.44B4.79B3.46B
Long-Term Debt1.42B1.4B2.86B2.77B2B3.21B3.54B3.12B3.12B1.81B
Capital Lease Obligations00114.69M116.77M127M99.27M113.68M99.51M103.11M306.26M
Deferred Tax Liabilities370.39M382.98M397.86M394.85M353.28M480.77M558.43M358.03M368.27M1.51B
Other Non-Current Liabilities946.4M858.5M982.82M901.5M809.58M729.65M753.95M789.78M863.33M3.78B
Total Liabilities3.93B3.82B5.77B5.98B5.17B7.27B8.61B6.41B6.59B5.03B
Total Debt1.84B1.71B3.19B3.69B2.52B3.32B4.28B3.62B3.3B1.88B
Net Debt700.07M1.15B2.57B2.94B2.08B1.82B3.39B2.42B1.68B792.02M
Debt / Equity0.48x0.45x0.78x0.83x0.43x0.40x0.44x0.35x0.34x0.34x
Debt / EBITDA2.24x1.84x3.55x4.87x3.20x1.18x6.38x-4.37x2.35x
Net Debt / EBITDA0.85x1.24x2.86x3.88x2.65x0.65x5.05x-2.23x2.23x
Interest Coverage5.40x13.82x11.88x7.19x8.66x20.34x2.08x-3.84x0.45x0.57x
Total Equity
3.82B▲ 0%
3.76B▼ 1.5%
4.09B▲ 8.9%
4.47B▲ 9.2%
5.81B▲ 29.9%
8.19B▲ 41.1%
9.67B▲ 18.0%
10.2B▲ 5.5%
9.78B▼ 4.1%
10.11B▲ 0%
Equity Growth %-3.17%-1.53%8.9%9.16%29.92%41.09%18%5.53%-4.1%-16.4%
Book Value per Share33.9734.3438.5041.8449.8269.5482.0786.7983.1085.22
Total Shareholders' Equity3.67B3.59B3.93B4.27B5.63B7.98B9.41B9.96B9.53B9.85B
Common Stock1.1M1.06M1.06M1.07M1.17M1.17M1.17M1.18M1.18M1.18M
Retained Earnings2.04B2.57B2.94B3.16B3.1B5.6B6.99B5.48B4.61B4.84B
Treasury Stock0000000000
Accumulated OCI-225.67M-350.68M-395.74M-326.13M-392.45M-560.66M-528.53M-742.06M-334.81M-259.11M
Minority Interest143.15M173.79M161.33M200.37M180.34M208.22M252.92M238.17M248.1M257.94M

ALB Cash Flow Statement

Albemarle Corporation (ALB) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations303.98M546.16M719.37M798.91M344.26M1.91B1.33B687.88M1.28B1.28B
Operating CF Margin %9.9%16.18%20.04%25.53%10.34%26.06%13.79%12.79%24.93%-
Operating CF Growth %-58.55%79.67%31.71%11.06%-56.91%454.19%-30.47%-48.15%86.41%57456.83%
Net Income99.47M739.14M604.36M446.62M199.94M2.82B1.67B-1.14B-465.21M-274.57M
Depreciation & Amortization196.93M200.7M213.48M231.98M254M300.84M429.94M588.64M658.68M654.73M
Stock-Based Compensation19.4M15.23M19.68M22.84M20.12M30.47M36.55M32.14M40.27M41.19M
Deferred Taxes-41.94M49.16M14.39M-1.98M-38.5M93.34M100.88M-230.41M81.17M85.83M
Other Non-Cash Items422.38M-306.1M-18.2M185.99M-203.03M82.77M95.93M696.11M272.98M-229.46M
Working Capital Changes-392.26M-151.97M-114.34M-86.53M111.72M-1.41B-1.01B736.87M694.38M716.37M
Change in Receivables-74.55M-97.45M-18.22M100.12M-49.3M-786.12M-350.65M555.22M47.31M0
Change in Inventory-101.55M-124.07M-46.3M51.98M-127.4M-1.61B-353.56M1.06B212.35M0
Change in Payables53.42M73.73M-12.23M-31.52M143.94M1.29B-283.41M-862.24M128.15M0
Cash from Investing-357.8M-303.69M-1.66B-863.57M-666.59M-1.42B-2.56B-1.58B-146.01M574.26M
Capital Expenditures-317.7M-699.99M-851.8M-850.48M-953.67M-1.26B-2.15B-1.68B-589.8M-505.85M
CapEx % of Revenue10.34%20.74%23.73%27.18%28.66%17.24%22.4%31.25%11.47%-
Acquisitions-39.83M402.17M-820M-11.57M283.3M-162.94M-427.43M-270K-239K-179K
Investments----------
Other Investing0010.36M06.49M706K029.1M32.81M1.04B
Cash from Financing-1.09B-786.53M1.04B177.26M50.21M611.89M623.91M1.24B-834.19M-2.13B
Debt Issued (Net)-612.46M-113.57M1.3B339.8M-1.11B867.55M944.2M-631.83M-454.67M-443.86M
Equity Issued (Net)-250M-500M001.45B002.24B00
Dividends Paid-140.56M-144.6M-152.2M-161.82M-177.85M-184.43M-187.19M-311.28M-357.28M-315.65M
Share Repurchases-250M-500M00000000
Other Financing-83.85M-28.36M-101.34M-719K-112.99M-71.24M-133.1M-51.91M-22.24M-1.37B
Net Change in Cash
-1.13B▲ 0%
-581.98M▲ 48.6%
57.79M▲ 109.9%
133.61M▲ 131.2%
-307.45M▼ 330.1%
1.06B▲ 444.7%
-609.24M▼ 157.5%
302.33M▲ 149.6%
425.77M▲ 40.8%
-428.7M▲ 0%
Free Cash Flow
-13.72M▲ 0%
-153.83M▼ 1020.9%
-132.42M▲ 13.9%
-51.56M▲ 61.1%
-609.41M▼ 1081.9%
646.2M▲ 206.0%
-827.96M▼ 228.1%
-992.65M▼ 19.9%
692.47M▲ 169.8%
577.27M▲ 0%
FCF Margin %-0.45%-4.56%-3.69%-1.65%-18.31%8.83%-8.61%-18.46%13.46%10.51%
FCF Growth %-102.56%-1020.85%13.91%61.06%-1081.87%206.04%-228.13%-19.89%169.76%469.12%
FCF per Share-0.12-1.41-1.25-0.48-5.235.49-7.03-8.455.885.88
FCF Conversion (FCF/Net Income)5.54x0.79x1.35x2.13x2.78x0.71x0.84x-0.58x-2.51x-2.10x
Interest Paid000027.73M92.09M101.98M150.69M180.71M0
Taxes Paid0000130.84M248.14M319.39M262.85M152.48M0

ALB Key Ratios

Albemarle Corporation (ALB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)1.41%18.31%13.58%8.78%2.41%38.44%17.62%-11.87%-5.11%-2.7%
Return on Invested Capital (ROIC)10.91%11.53%8.88%5.6%5.22%20.97%1.57%-3.72%0.58%0.58%
Gross Margin36.57%36.18%35.07%31.82%30.3%42.15%12.49%1.12%13.06%18.53%
Net Margin1.79%20.55%14.86%12.01%3.72%36.75%16.36%-21.93%-9.93%-5%
Debt / Equity0.48x0.45x0.78x0.83x0.43x0.40x0.44x0.35x0.34x0.34x
Interest Coverage5.40x13.82x11.88x7.19x8.66x20.34x2.08x-3.84x0.45x0.57x
FCF Conversion5.54x0.79x1.35x2.13x2.78x0.71x0.84x-0.58x-2.51x-2.10x
Revenue Growth14.75%9.86%6.35%-12.83%6.36%119.96%31.38%-44.08%-4.37%7.87%

ALB SEC Filings & Documents

Albemarle Corporation (ALB) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Apr 17, 2026·SEC

Material company update

Mar 25, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 11, 2026·SEC

FY 2025

Feb 12, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 4, 2025·SEC

ALB Frequently Asked Questions

Albemarle Corporation (ALB) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Albemarle Corporation (ALB) reported $5.49B in revenue for fiscal year 2025. This represents a 543% increase from $854.5M in 1996.

Albemarle Corporation (ALB) saw revenue decline by 4.4% over the past year.

Albemarle Corporation (ALB) reported a net loss of $274.6M for fiscal year 2025.

Dividend & Returns

Yes, Albemarle Corporation (ALB) pays a dividend with a yield of 0.84%. This makes it attractive for income-focused investors.

Albemarle Corporation (ALB) has a return on equity (ROE) of -5.1%. Negative ROE indicates the company is unprofitable.

Albemarle Corporation (ALB) generated $577.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More ALB

Albemarle Corporation (ALB) financial analysis — history, returns, DCA and operating performance tools

Full ALB Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.